Scientists test malaria shot in vulnerable kids
NCT ID NCT05385510
Summary
This study tested the safety and immune response of a new malaria vaccine in young African children, most of whom were living with HIV. Researchers gave 122 children aged 5-36 months a series of three vaccine shots plus a booster. The main goal was to see if the vaccine was safe and how well it triggered an immune response in children with HIV compared to those without.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MRC/UVRI & LSHTM Uganda Research Unit
Entebbe, Uganda
Conditions
Explore the condition pages connected to this study.